
Inhibikase Therapeutics Inc (IKT)
US$ 3.0818.46%
Price Chart
Key Statistics
Market Cap
$ 124.15M
P/E Ratio
0.00
Revenue (TTM)
$ 1
Volume
257.63K
52W High
$ 4.20
52W Low
$ 1.12
Dividend Yield
0.00%
Beta
0.94
Technicals
50-Day MA
1.9721
200-Day MA
2.2379
52 Week High
4.2
52 Week Low
1.12
About IKT
Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson's disease and related disorders.
Employees
15
Headquarters
Atlanta, GA
CEO
Mr. Mark T. Iwicki
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg